As of 2025-07-07, the Relative Valuation of Paratek Pharmaceuticals Inc (PRTK) is (21.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.23 USD, the upside of Paratek Pharmaceuticals Inc based on Relative Valuation is -1047.2%.
The range of the Relative Valuation is (21.04) - (20.20) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.4x - 18.5x | 18.0x |
| Forward P/E multiples | 19.2x - 22.3x | 20.6x |
| Fair Price | (21.04) - (20.20) | (21.12) |
| Upside | -1043.3% - -1006.0% | -1047.2% |
| Date | P/E |